Glendon E. French III - 01 Dec 2023 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Issuer symbol
LUNG
Transactions as of
01 Dec 2023
Net transactions value
-$69,030
Form type
4
Filing time
05 Dec 2023, 17:41:23 UTC
Previous filing
06 Sep 2023
Next filing
22 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $10,754 -1,040 -0.09% $10.34 1,166,980 01 Dec 2023 Direct F1
transaction LUNG Common Stock Sale $16,451 -1,591 -0.14% $10.34 1,165,389 01 Dec 2023 Direct F2
transaction LUNG Common Stock Sale $41,825 -4,045 -0.35% $10.34 1,161,344 01 Dec 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.